Nanoform Finland has announced a pre-clinical development agreement with the plasma-derived therapies business unit of Takeda to develop new formulations for the treatment of rare conditions. This collaboration will leverage Nanoform’s nanoforming technology to enhance the performance of plasma-derived therapies.
Nanoform Contract Manufacturing & Development (CDMO) Profile Nanoform is the medicine performance-enhancing company that leverages best-in-class innovative nanoparticle engineering technologies, expert formulation, and scalable GMP nano-API manufacturing to enable superior medicines for patients. The company focuses on reducing clinical attrition
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
